{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:42:02Z","timestamp":1790912522380,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,13]],"date-time":"2027-07-13T00:00:00Z","timestamp":1815436800000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jchromb.2026.125206","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:55:13Z","timestamp":1783601713000},"page":"125206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ultrafast affinity extraction with non-covalent entrapment for biointeraction analysis: development and applications to single- and multi-site drug-protein binding"],"prefix":"10.1016","volume":"1281","author":[{"given":"Isaac","family":"Kyei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungah","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigar Sultana","family":"Pinky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125206_bb0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jssc.200800640","article-title":"Characterization of drug\u2013protein interactions in blood using high-performance affinity chromatography","volume":"32","author":"Hage","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.64719\/pb.4210","article-title":"Clinical significance of drug binding, protein binding, and binding displacement drug interactions","volume":"36","author":"DeVane","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jchromb.2026.125206_bb0015","series-title":"Encyclopedia of Drug Metabolism and Interactions","first-page":"1","article-title":"The significance and determination of plasma protein binding","author":"Damre","year":"2012"},{"key":"10.1016\/j.jchromb.2026.125206_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00216-010-3737-1","article-title":"Drug\u2013protein binding: a critical review of analytical tools","volume":"398","author":"Vuignier","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0025","first-page":"546","article-title":"Drug interactions\u2014principles, examples and clinical consequences","volume":"109","author":"Cascorbi","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jchromb.2026.125206_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.09.007","article-title":"High-performance affinity chromatography: applications in drug\u2013protein binding studies and personalized medicine","volume":"102","author":"Li","year":"2016","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jchromb.2026.125206_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/clinchem\/45.5.593","article-title":"Affinity chromatography: a review of clinical applications","volume":"45","author":"Hage","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jssc.201400914","article-title":"Comparison of various capillary electrophoretic approaches for the study of drug-protein interaction with emphasis on minimal consumption of protein sample and possibility of automation","volume":"38","author":"Michalcov\u00e1","year":"2014","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0045","series-title":"ADME-enabling Technol. Drug Des. Dev.","first-page":"177","author":"Lloyd","year":"2012"},{"key":"10.1016\/j.jchromb.2026.125206_bb0050","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1002\/anie.200500503","article-title":"The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping","volume":"44","author":"Sanchez-Pedregal","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jchromb.2026.125206_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1039\/c2np00098a","article-title":"NMR in natural products: understanding conformation, configuration and receptor interactions","volume":"29","author":"Carlomagno","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jchromb.2026.125206_bb0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/cbic.201000756","article-title":"STD and trNOESY NMR study of receptor-ligand interactions in living cancer cells","volume":"12","author":"Potenza","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jchromb.2026.125206_bb0065","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/molecules28093724","article-title":"Molecular basis for the selectivity of DHA and EPA in Sudlow's drug binding sites in human serum albumin with the combined use of NMR and docking calculations","volume":"28","author":"Alexandri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125206_bb0070","first-page":"11796","article-title":"INPHARMA-based determination of ligand binding modes at \u03b11-adrenergic receptors explains the molecular basis of subtype selectivity","volume":"26","author":"Vaid","year":"2020","journal-title":"ChemEurJ"},{"key":"10.1016\/j.jchromb.2026.125206_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpba.2012.10.030","article-title":"High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug\u2013plasma protein interactions","volume":"74","author":"Vuignier","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125206_bb0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/00498250802109207","article-title":"Determination and modelling of stereoselective interactions of ligands with drug transporters: a key dimension in the understanding of drug disposition","volume":"38","author":"Bhatia","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2026.125206_bb0085","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jssc.200800685","article-title":"Kinetic studies of biological interactions by affinity chromatography","volume":"32","author":"Schiel","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0090","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.chroma.2010.09.070","article-title":"Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug\u2013protein dissociation rates","volume":"1218","author":"Yoo","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0095","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.chroma.2010.10.070","article-title":"Kinetic studies of drug\u2013protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns","volume":"1218","author":"Tong","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0100","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/jssc.201100280","article-title":"High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths","volume":"34","author":"Yoo","year":"2011","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0105","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1021\/ac052017b","article-title":"Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs","volume":"78","author":"Chen","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123047","article-title":"Evaluation of microcolumn stability in ultrafast affinity extraction for binding and rate studies","volume":"1187","author":"Iftekhar","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125206_bb0115","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/ac501031y","article-title":"Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"86","author":"Zheng","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00216-015-9082-7","article-title":"Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography","volume":"408","author":"Zheng","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chroma.2015.12.084","article-title":"Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using \u03b11-acid glycoprotein microcolumns","volume":"1432","author":"Bi","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462240","article-title":"Characterization of drug binding with alpha1-acid glycoprotein in clinical samples using ultrafast affinity extraction","volume":"1649","author":"Beeram","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chroma.2017.03.056","article-title":"Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling","volume":"1497","author":"Beeram","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2018.02.021","article-title":"Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"146","author":"Beeram","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.jchromb.2026.125206_bb0145","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.chroma.2010.02.026","article-title":"Analysis of drug\u2013protein binding by ultrafast affinity chromatography using immobilized human serum albumin","volume":"1217","author":"Mallik","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0150","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1039\/c3an01315d","article-title":"Analysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatography","volume":"138","author":"Zheng","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.jchromb.2026.125206_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464307","article-title":"Determination of binding constants by ultrafast affinity extraction: theoretical and experimental studies of optimum conditions for analysis","volume":"1707","author":"Iftekhar","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123500","article-title":"Analysis of the binding of warfarin to glyoxal-and methylglyoxal-modified human serum albumin by ultrafast affinity extraction","volume":"1211","author":"Iftekhar","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125206_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2014.10.092","article-title":"Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin","volume":"1371","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0170","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1021\/acs.analchem.5b03007","article-title":"Analysis of hormone\u2013protein binding in solution by ultrafast affinity extraction: interactions of testosterone with human serum albumin and sex hormone binding globulin","volume":"87","author":"Zheng","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0175","doi-asserted-by":"crossref","unstructured":"B. Yang, X. Zheng, D.S. Hage, Binding studies based on ultrafast affinity extraction and single- or two-column systems: interactions of second- and third-generation sulfonylurea drugs with normal or glycated human serum albumin, J. Chromatogr. B 1102\u20131103 (2018) 8\u201316.","DOI":"10.1016\/j.jchromb.2018.10.015"},{"key":"10.1016\/j.jchromb.2026.125206_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2010.05.004","article-title":"Entrapment of proteins in glycogen-capped and hydrazide-activated supports","volume":"404","author":"Jackson","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2019.05.004","article-title":"Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent","volume":"1121","author":"Vargas-Badilla","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125206_bb0190","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1007\/s00216-016-9677-7","article-title":"On-column entrapment of alpha 1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography","volume":"408","author":"Anguizola","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0195","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","article-title":"Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin","volume":"405","author":"Jackson","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jchromb.2015.11.021","article-title":"Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies","volume":"1021","author":"Bi","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125206_bb0205","series-title":"Handbook of Affinity Chromatography","first-page":"35","article-title":"Immobilization methods for affinity chromatography","author":"Kim","year":"2006"},{"key":"10.1016\/j.jchromb.2026.125206_bb0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.chemphys.2007.07.027","article-title":"Effect of solvation on the structure conformation of human serum albumin in aqueous\u2013alcohol mixed solvents","volume":"340","author":"Taboada","year":"2007","journal-title":"Chem. Phys."},{"key":"10.1016\/j.jchromb.2026.125206_bb0215","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.3390\/ijms262412192","article-title":"Human serum albumin: 3D insight on protein hydration","volume":"26","author":"Fedotova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0220","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/ac00093a043","article-title":"Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin","volume":"66","author":"Loun","year":"1994","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114097","article-title":"High-performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal-or methylglyoxal-modified human albumin serum","volume":"201","author":"Ovbude","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125206_bb0230","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1002\/jssc.202200686","article-title":"Characterization of binding by repaglinide and nateglinide with glycated human serum albumin using high-performance affinity microcolumns","volume":"45","author":"Ovbude","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9673(94)80332-3","article-title":"Development of dihydrazide-activated silica supports for high-performance affinity chromatography","volume":"669","author":"Ruhn","year":"1994","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0240","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jchromb.2010.04.028","article-title":"Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug\u2013protein binding","volume":"878","author":"Yoo","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125206_bb0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abio.2001.5314","article-title":"High-resolution and high-throughput protocols for measuring drug\/human serum albumin interactions using BIACORE","volume":"296","author":"Rich","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0250","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jssc.200900074","article-title":"Noncompetitive peak decay analysis of drug\u2013protein dissociation by high-performance affinity chromatography","volume":"32","author":"Chen","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125206_bb0255","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/ac950827p","article-title":"Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)-and (S)-warfarin binding to immobilized human serum albumin","volume":"68","author":"Loun","year":"1996","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125206_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.343520","article-title":"Development and use of DJ-1 affinity microcolumns to screen and study small drug candidates for Parkinson's disease","volume":"1336","author":"Jones","year":"2025","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125206_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340629","article-title":"Preparation of entrapment-based microcolumns for analysis of drug-humic acid interactions by high-performance affinity chromatography","volume":"1239","author":"Iftekhar","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125206_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465427","article-title":"Analysis of interactions between pharmaceuticals and humic acid: characterization using entrapment and high-performance affinity microcolumns","volume":"1737","author":"Sharmeen","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125206_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.70345","article-title":"Chromatographic-based binding and thermodynamic studies of antibiotic micropollutants with humic acid using affinity microcolumns","volume":"49","author":"Sharmeen","year":"2026","journal-title":"J. Sep. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:24:09Z","timestamp":1785515049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S1570023226002953"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125206","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrafast affinity extraction with non-covalent entrapment for biointeraction analysis: development and applications to single- and multi-site drug-protein binding","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125206"}}